Table 1.
Participant characteristics and questionnaire scores.
Fig 1.
CAPS scores for the participants with and without ASC.
Error bars = +/- 1 standard error. (A) shows the percentage of items endorsed for the whole scale (total), for the temporal lobe experience component (C1), for the chemosensation component (C2) and for the clinical psychosis component (C3). (B) shows the scaled level of intrusion, level of distress, and the frequency of anomalous perception reported by each group.
Fig 2.
Number of endorsements given to each CAPS item by the participants with and without ASC.
For ease of viewing, items have been ordered in terms of increasing numbers of participants with ASC who endorsed the item.
Fig 3.
Scatterplot showing SRS T-scores and CAPS total scores.
Participants with ASC are indicated by red diamonds. Participants without ASC are indicated by blue triangles. Linear regression lines for the two groups are also shown.
Fig 4.
A comparison of the data collected here and previous data published by Bell et al. 2006.
(A) Raw CAPS scores (means and standard deviations) from 337 neurotypical participants and 20 psychotic inpatients. Reprinted from Bell et al. (2006), Schizophrenia Bulletin. 2006; 32(2), 366–77, Oxford University Press, under a CC BY license, with permission from Professor Peter Halligan, original copyright 2005. (B) Raw CAPS scores (means and standard deviations) from 30 neurotypical participants and 30 participants with ASC (this study).